Related references
Note: Only part of the references are listed.Burden of Gastric Cancer
Aaron P. Thrift et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
The 2019 WHO classification of tumours of the digestive system
Iris D. Nagtegaal et al.
HISTOPATHOLOGY (2020)
Neoadjuvant chemotherapy vs upfront surgery for gastric signet ring cell carcinoma: A retrospective, propensity score-matched study
Yang Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Global Burden of 5 Major Types of Gastrointestinal Cancer
Melina Arnold et al.
GASTROENTEROLOGY (2020)
miR-99a-5p as Possible Diagnostic and Prognostic Marker in Patients With Gastric Cancer
Ryo Saito et al.
JOURNAL OF SURGICAL RESEARCH (2020)
Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma
C. Mariette et al.
GASTRIC CANCER (2019)
Deficiency of mismatch repair genes is less frequently observed in signet ring cell compared with non-signet ring cell gastric cancer
Yosuke Hirotsu et al.
MEDICAL ONCOLOGY (2019)
Perioperative Treatment in Resectable Gastric Cancer: Current Perspectives and Future Directions
Angelica Petrillo et al.
CANCERS (2019)
Where does signet-ring cell carcinoma come from and where does it go?
Tomio Arai
GASTRIC CANCER (2019)
Survival benefit of palliative gastrectomy followed by chemotherapy in stage IV gastric signet ring cell carcinoma patients: A large population-based study
Tao Shi et al.
CANCER MEDICINE (2019)
Postoperative Radiotherapy Improves Survival in Gastric Signet-Ring Cell Carcinoma: a SEER Database Analysis
Feng Wei et al.
JOURNAL OF GASTRIC CANCER (2019)
Neoadjuvant Therapy Improves Outcomes in Locally Advanced Signet-Ring-Cell Containing Esophagogastric Adenocarcinomas
Ulrike Heger et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Efficacy of a docetaxel-5FU-oxaliplatin regimen (TEFOX) in first-line treatment of advanced gastric signet ring cell carcinoma: an AGEO multicentre study
Simon Pernot et al.
BRITISH JOURNAL OF CANCER (2018)
Incidence, Survival, and Predictors of Lymph Node Involvement in Early-Stage Gastric Signet Ring Cell Carcinoma in the US
Sridevi K. Pokala et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2018)
Prognostic significance of frequent CLDN18-ARHGAP26/6 fusion in gastric signet-ring cell cancer
Yang Shu et al.
NATURE COMMUNICATIONS (2018)
A proteomic landscape of diffuse-type gastric cancer
Sai Ge et al.
NATURE COMMUNICATIONS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Survival predictors associated with signet ring cell carcinoma of the esophagus (SRCCE): A population-based retrospective cohort study
Zihao Wan et al.
PLOS ONE (2017)
Mismatch Repair Deficiency, Microsatellite Instability, and Survival An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial
Elizabeth C. Smyth et al.
JAMA ONCOLOGY (2017)
Is signet-ring cell carcinoma a specific entity among gastric cancers?
Thibault Voron et al.
GASTRIC CANCER (2016)
Signet Ring Cells and Efficacy of First-line Chemotherapy in Advanced Gastric or Oesogastric Junction Adenocarcinoma
Nathalie Lemoine et al.
ANTICANCER RESEARCH (2016)
miR-935 suppresses gastric signet ring cell carcinoma tumorigenesis by targeting Notch1 expression
Chao Yan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Gastric Cancer, Version 3.2016
Jaffer A. Ajani et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2016)
The Proportion of Signet Ring Cell Component in Patients with Localized Gastric Adenocarcinoma Correlates with the Degree of Response to Pre-Operative Chemoradiation
Nikolaos Charalampakis et al.
ONCOLOGY (2016)
Intramucosal gastric cancer: the rate of lymph node metastasis in signet ring cell carcinoma is as low as that in well-differentiated adenocarcinoma
Sang Heon Lee et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2015)
Screening of differential microRNA expression in gastric signet ring cell carcinoma and gastric adenocarcinoma and target gene prediction
Jian Chen et al.
ONCOLOGY REPORTS (2015)
Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge
Simon Pernot et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus
Markus Moehler et al.
GASTRIC CANCER (2015)
The Impact of Preoperative Radiochemotherapy on Survival in Advanced Esophagogastric Junction Signet Ring Cell Adenocarcinoma
Sarah Bekkar et al.
ANNALS OF THORACIC SURGERY (2014)
GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study
Olivier Glehen et al.
BMC CANCER (2014)
Does Adjuvant Radiotherapy Benefit Patients With Diffuse-Type Gastric Cancer? Results From the Surveillance, Epidemiology, and End Results Database
Alexander M. Stessin et al.
CANCER (2014)
Tumour size is related to the curability of signet ring cell early gastric cancer with endoscopic submucosal dissection: A retrospective single centre study
Mi Na Kim et al.
DIGESTIVE AND LIVER DISEASE (2014)
Signet ring cell adenocarcinomas: Different clinical-pathological characteristics of oesophageal and gastric locations
G. Piessen et al.
EJSO (2014)
Predictive factors for lymph node metastasis in early gastric cancer with signet ring cell histology and their impact on the surgical strategy: analysis of single institutional experience
Zheng Wang et al.
JOURNAL OF SURGICAL RESEARCH (2014)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
Initial Clinical Experience with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Signet-Ring Cell Gastric Cancer with Peritoneal Metastases
Ingmar Koenigsrainer et al.
JOURNAL OF GASTRIC CANCER (2014)
Phase II/III multicentre randomised controlled trial evaluating a strategy of primary surgery and adjuvant chemotherapy versus peri-operative chemotherapy for resectable gastric signet ring cell adenocarcinomas - PRODIGE 19 - FFCD1103 - ADCI002
Guillaume Piessen et al.
BMC CANCER (2013)
Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial
Jeeyun Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Updated Analysis of SWOG-Directed Intergroup Study 0116: A Phase III Trial of Adjuvant Radiochemotherapy Versus Observation After Curative Gastric Cancer Resection
Stephen R. Smalley et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Gastric cancer: Classification, histology and application of molecular pathology
Bing Hu et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2012)
The Impact of Perioperative Chemotherapy on Survival in Patients With Gastric Signet Ring Cell Adenocarcinoma A Multicenter Comparative Study
Mathieu Messager et al.
ANNALS OF SURGERY (2011)
Japanese classification of gastric carcinoma: 3rd English edition
GASTRIC CANCER (2011)
Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer
Mitsuru Sasako et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Retrospective Analysis of Adjuvant Intraperitoneal Chemotherapy Effect Prognosis of Resectable Gastric Cancer
Chunmei Shi et al.
ONCOLOGY (2011)
Clinicopathologic Features of Gastric Carcinoma with Signet Ring Cell Histology
Ming Zhang et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2010)
Signet Ring Cell Histology is an Independent Predictor of Poor Prognosis in Gastric Adenocarcinoma Regardless of Tumoral Clinical Presentation
Guillaume Piessen et al.
ANNALS OF SURGERY (2009)
Is it reasonable to treat early gastric cancer with signet ring cell histology by endoscopic resection? Analysis of factors related to lymph-node metastasis
Jae Myung Park et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2009)
Advanced gastric carcinoma with signet ring cell histology
Chen Li et al.
ONCOLOGY (2007)
Matrilsin expression is a useful marker of submucosal invasion and lymph node metastasis in early stage signet ring cell carcinoma of the stomach
R Aihara et al.
JOURNAL OF SURGICAL ONCOLOGY (2006)
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.
JS Macdonald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
